We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Vandetanib and Sirolimus in Patients With Recurrent Glioblastoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00821080
Recruitment Status : Completed
First Posted : January 13, 2009
Last Update Posted : May 1, 2015
Sponsor:
Collaborators:
Brigham and Women's Hospital
Dana-Farber Cancer Institute
AstraZeneca
Information provided by (Responsible Party):
Tracy T. Batchelor, MD, Massachusetts General Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : February 2015
  Study Completion Date : February 2015